In this situation, the patient had steroid-refractory myocarditis and was given abatacept (CTLA4 and PD1/PDL1 pathway inhibitor) along with ruxolitinib (Janus Kinase inhibitor). This evidence concerns the gene CTLA4 and myocarditis.